Rhythm Pharmaceuticals (RYTM) Gross Profit (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Gross Profit of $53.0 million for Q1 2026, up 82.25% year-over-year from $29.1 million in Q1 2025, and up 0.96% quarter-over-quarter from $52.5 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Gross Profit (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Gross Profit for 6 consecutive years, with $53.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit rose 82.25% year-over-year to $53.0 million; the TTM figure through Mar 2026 stood at $194.2 million (up 58.3% YoY), while the FY2025 annual figure was $170.3 million, up 45.83% from the prior year.
- Gross Profit rose to $53.0 million in Q1 2026 per RYTM's latest filing, from $52.5 million in the prior quarter.
- Across five years, Gross Profit topped out at $53.0 million in Q1 2026 and bottomed at -$9.1 million in Q4 2022.
- Historically, Gross Profit has averaged $24.3 million across 5 years, with a median of $23.2 million in 2024.
- On a YoY basis, Gross Profit climbed as much as 6241.61% in 2022 and fell as far as 674.07% in 2022.
- Rhythm Pharmaceuticals' Gross Profit stood at -$9.1 million in 2022, then soared by 331.39% to $21.0 million in 2023, then jumped by 81.15% to $38.0 million in 2024, then surged by 37.87% to $52.5 million in 2025, then advanced by 0.96% to $53.0 million in 2026.
- Business Quant data shows RYTM's Gross Profit at $53.0 million in Q1 2026, $52.5 million in Q4 2025, and $45.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.32 Mn |
| Jun 30, 2026 | 62.32 Mn |
| Mar 31, 2026 | 52.96 Mn |
| Mar 31, 2026 | 52.96 Mn |
| Dec 31, 2025 | 52.45 Mn |
| Dec 31, 2025 | 52.45 Mn |
| Sep 30, 2025 | 45.80 Mn |
| Sep 30, 2025 | 45.80 Mn |
| Jun 30, 2025 | 42.96 Mn |
| Jun 30, 2025 | 42.96 Mn |
| Mar 31, 2025 | 29.06 Mn |
| Mar 31, 2025 | 29.06 Mn |
| Dec 31, 2024 | 38.04 Mn |
| Dec 31, 2024 | 38.04 Mn |
| Sep 30, 2024 | 29.42 Mn |
| Sep 30, 2024 | 29.42 Mn |
| Jun 30, 2024 | 26.13 Mn |
| Jun 30, 2024 | 26.13 Mn |
| Mar 31, 2024 | 23.16 Mn |
| Mar 31, 2024 | 23.16 Mn |